Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published 1 June 2009
Cite this as: BMJ Case Reports 2009 [doi:10.1136/bcr.08.2008.0626]
Copyright © 2009 by the BMJ Publishing Group Ltd.

Images In...

Scleromyexdema?

Noha Mohamed El Hossainy1, Medhat Morsy El Fatatry2

1 Cairo University, Internal Medicine, Faculty of Medicine - Cairo University, Giza, 12351, Egypt
2 Cairo University, Internal Medicine, Faculty of Medicine – Cairo University, Giza, 11111, Egypt

Correspondence to:
Noha Mohamed El Hossainy, dr_noha2002{at}yahoo.com

Scleromyxoedema is an uncommon disease that is clinically characterised by widespread progressive induration of the skin of the fingers and extremities. Patients may also have cysts and urticarial lesions.1 Most patients with this disorder present with monoclonal paraproteinaemia, mainly IgG lambda. Oesophageal abnormalities with dysphagia, muscle weakness, dyspnoea with restrictive lung disease and cor pulmonale, pericardial effusions, central nervous system abnormalities and neuropathies, arthralgias and Raynaud’s phenomenon have been observed and may be associated with significant morbidity and mortality.2

Various agents have been proposed in case reports and small series for treatment of this condition with variable success. IVIG and thalidomide in combination may be an effective novel treatment of scleromyxoedema. Additionally, skin ultrasonography, a non-invasive test, may become a useful diagnostic and disease activity monitoring tool.3

The 40-year-old female patient presented with skin nodules in legs and hardening of skin especially in the forearms (figs 14). This is not typical for scleroderma and so we proceeded to skin biopsy, which revealed deposition of mucinous material in the dermis. In scleroderma, there is excess collagen fibre deposition. The patient has no dyspnoea or dysphagia. Protein electrophoresis was normal.


 


 


 


 


LEARNING POINTS

  • Scleromyxoedema is a skin disease with or without systemic manifestations not related to scleroderma or to myxoedema (normal thyroid function).
  • The diagnosis of scleromyxoedema is a clinicopathological diagnosis.
  • Treatment is usually unsatisfactory and may include phototherapy, steroids and creams but results are poor.


Dr Mohamed El Daroty, Professor of Dermatology, who revised the skin biopsy.

Competing interests: none.

Patient consent: Patient/guardian consent was obtained for publication.

REFERENCES

  1. Liotta, A. Lichen Myxedematosus. 2006. http://www.emedicine.com (accessed 21 May 2009).
  2. Gwinner, W, Erdbruegger, U, Mengel, M, et al. Scleroderma-like acute renal crisis in a patient with scleromyxedema. Nephrol Dial Transplant 2007; 22: 2063–7.[Free Full Text]
  3. Efthimiou, P, & Blanco, M. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum 2008; 3: 188–94.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) -   become a fellow  today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts  so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog